In May 2016, a class-action lawsuit was filed against Alere for, among other things, allegedly deceptively marketing INRatio products (i.e., electronic testing devices designed to help patients who take blood thinners monitor blood clotting times), including INRatio PT/INR monitors and test strips, and INRatio2 PT/INR monitors and test strips. According to the complaint, the company markets the products as “accurate” and “reliable” though it has been notified that the results produced by INRatio products are different than those produced by independent laboratories. (Andren et al v. Alere Inc., Alere Home Monitoring, Inc., and Alere San Diego, Inc., Case No. 16-cv-1255, S. D. CA.)


The Latest

Filters

Fisher Investments

Ad Alert

Fisher Investments

Unearthing the fees that Fisher charges but doesn’t disclose in some of its TV ads.


Show More